欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease

2026-07-06
SPIL Q4FY26 Financial Results

2026-07-06
Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

2026-07-06
UK Asks Industry To Identify High-Impact Areas For Animal Testing Alternatives

2026-07-06
WHO urges scale up of newborn screening to improve early detection and care of birth defects

2026-07-06
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2026

2026-07-05
New EU Approvals

2026-07-05
Bristol Myers Squibb Announces Dividend

2026-07-05
Aurobindo Receives FDA Approval for Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL

2026-07-05
Dr Reddy’s Chief On Gains From gRevlimid, Patient Capital To Drive Innovation In India

2026-07-05
Rare Disease Could Boost China’s Growing Influence Over Early-Stage RD

2026-07-04
UK Asks Industry To Identify High-Impact Areas For Animal Testing Alternatives

2026-07-04